Biodistribution and environmental safety of a live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

New platforms are needed for the design of novel prophylactic vaccines and advanced immune therapies. Live-attenuated yellow fever vaccine YF17D serves as a vector for several licensed vaccines and platform for novel candidates. On the basis of YF17D, we developed an exceptionally potent COVID-19 va...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li-Hsin, Liesenborghs, Laurens, Wang, Lanjiao, Lox, Marleen, Yakass, Michael Bright, Jansen, Sander, Rosales Rosas, Ana Lucia, Zhang, Xin, Thibaut, Hendrik Jan, Teuwen, Dirk, Neyts, Johan, Delang, Leen, Dallmeier, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925082/
https://www.ncbi.nlm.nih.gov/pubmed/35313504
http://dx.doi.org/10.1016/j.omtm.2022.03.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925082/
https://www.ncbi.nlm.nih.gov/pubmed/35313504
http://dx.doi.org/10.1016/j.omtm.2022.03.010

Ejemplares similares